about
Tackling dengue fever: Current status and challengesDengue Fever: Causes, Complications, and Vaccine StrategiesVaccine-mediated immunity against dengue and the potential for long-term protection against diseaseDengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral SerotypesMolecular engineering and plant expression of an immunoglobulin heavy chain scaffold for delivery of a dengue vaccine candidateBacteriophages and Their Immunological Applications against Infectious Threats.Zika Virus: Recent Advances towards the Development of Vaccines and Therapeutics.Social sciences research on infectious diseases of poverty: too little and too late?Dengue vaccines: recent developments, ongoing challenges and current candidates.Immunogenicity and efficacy of flagellin-envelope fusion dengue vaccines in mice and monkeys.Cooperation between CD4+ T Cells and Humoral Immunity Is Critical for Protection against Dengue Using a DNA Vaccine Based on the NS1 AntigenDNA vaccines: roles against diseases.Targeting host factors to treat West Nile and dengue viral infections.Using bacteria to treat diseases.Challenges for the formulation of a universal vaccine against dengue.Challenges in reducing dengue burden; diagnostics, control measures and vaccines.Developing a dengue vaccine: progress and future challenges.Oleic acid Enhances Dengue Virus But Not Dengue Virus-Like Particle Production from Mammalian Cells.Antibody production by in vivo RNA transfection.
P2860
Q24288867-8ABA3B36-3E70-4B56-A045-620845D94CB7Q26700082-61558B8A-DD43-49B5-B083-05B7A35FD8DCQ27014663-BA139D0A-8662-431E-BBA6-B36882540943Q27304342-EED81CBF-6155-43DB-8489-7B3F144EE347Q29587283-FCB579C4-EF0F-491E-92DF-CB5C58BFBFFBQ30234522-EC1B1320-29E0-410C-A134-60204F0F1FAAQ32183208-1970EAEF-6EDE-4FD6-8639-B0BD18E40534Q33747817-8AEAA75C-DDDD-491A-B893-521D439964EBQ34367194-8EA13985-EA1F-4B63-A9CB-3F7E9C15D79BQ35548048-22128E3A-69A4-4D34-AE34-FFB2C772FE49Q35864468-8039302C-368A-4488-BB44-B0B4C2FFDD68Q37441566-A441CD30-F873-4CC9-A687-5F9CEDC53218Q37611829-EC193F09-24FC-4FA9-A0A7-75C5703A5A13Q38002453-90A22AD2-C1E1-4FB0-A9D3-7FDF6611B13AQ38121757-192A3626-9D7D-4AF8-A5B0-C483FF11A866Q38140035-0CF837E0-5E08-49CA-887F-ED627D86856CQ38201151-12479369-8C6B-4EB7-89B4-55915E590D1AQ40044051-0658B9F1-3DD5-4DA0-A2C4-731303956570Q40052131-8C9946B9-B3A5-4554-BB56-957191FD3A9D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of dengue DNA vaccines.
@en
Development of dengue DNA vaccines.
@nl
type
label
Development of dengue DNA vaccines.
@en
Development of dengue DNA vaccines.
@nl
prefLabel
Development of dengue DNA vaccines.
@en
Development of dengue DNA vaccines.
@nl
P2093
P1433
P1476
Development of dengue DNA vaccines.
@en
P2093
Charmagne G Beckett
Janine R Danko
Kevin R Porter
P304
P356
10.1016/J.VACCINE.2011.07.019
P407
P577
2011-07-21T00:00:00Z